Healthcare CRM Market: Trends and Developments

The benefits of CRM software and a growing focus on patient engagement are the major factors driving the growth of the healthcare CRM market. Factors such as the improving quality of healthcare, improvements in healthcare systems, the growing medical tourism market in Asian countries, and increasing government initiatives are the key factors driving the growth of this market.

The report Healthcare CRM Market  is projected to reach USD 17.4 billion by 2023 from USD 8.8 billion in 2018, at a CAGR of 14.6% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=88873203

Market Segmentation:-

Based on end user, the healthcare CRM market is segmented into healthcare providers, the life sciences industry, and healthcare payers. The healthcare providers segment is estimated to account for the largest share of the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Healthcare providers need to interact with multiple stakeholders, including patients, physicians, other referral healthcare organizations, healthcare payer organizations, pharmaceutical companies, and consumers/potential patients, and each requires unique CRM strategies and solutions.

On the basis of component, the healthcare CRM market is segmented into software and services. The services segment is expected to dominate the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Services form a large component of the healthcare CRM market primarily due to the indispensable role of service providers when it comes to the use of CRM solutions for healthcare. In terms of IT usage and skills, the healthcare industry is still in the nascent stage; it relies heavily on service providers for CRM-related services and support services, such as implementation, integration, training and education, maintenance, and technology upgrades.

Recent Developments:-

• In 2018, Salesforce launched Salesforce Integration Cloud.
• In 2018, IBM partnered with Salesforce. This partnership aimed to bring together Cloud and Watson services from IBM with Salesforce Quip and Salesforce Service cloud Einstein to allow organizations to connect with their customers more effectively.
• In 2018, SAP acquired Caliduscloud (US) to strengthen its cloud-based customer relationship management solution.

Regional Analysis:-

Geographically, the global healthcare CRM market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to hold the largest share of the healthcare CRM market.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=88873203

Top Key Players:-

The key players in the healthcare CRM market are Salesforce.com, Inc. (US), SAP SE (Germany), Oracle (US), Microsoft (US), IBM (US), Influence Health (US), SugarCRM (US), Accenture (Ireland), Healthgrades (US), and Infor, Inc. (US).

 

Gene Expression Analysis Market to Progress at a Healthy CAGR in Coming Years

The major factors driving the growth of the gene expression analysis market include decreasing cost of sequencing, rising prevalence of cancer, growing application areas of genomics, and the availability of gene expression databases.

The report Gene Expression Analysis Market is expected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018, at a CAGR of 8.8%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968

Market Segmentation:-                                                                        

On the basis of products and services, the global Gene Expression Analysis Industry has been segmented into consumables (reagents, DNA chips), Instruments (PCR, NGS, Microarray, others), and services (gene expression profiling services, bioinformatics solutions). The consumables segment is estimated to command the largest share of the market in 2018 and is also projected to register the highest CAGR.

Based on end user, the market has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and other end users. The pharmaceutical and biotechnology companies segment is expected to command the largest share of 54.8% of the market in 2018.

Recent Developments

• In January 2017, Biorad acquired of RainDance Technologies, a droplet-based PCR systems manufacturer. RainDance Technologies has a more focused portfolio, primarily known for its droplet-based technologies for digital PCR (dPCR).
• In March 2016, Thermo Fisher Scientific completes acquisition of Affymetrix, a leading provider of cellular and genetic analysis products.

Regional Analysis:-

Geographically, North America is expected to dominate the global gene expression analysis market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=156613968

Top Key Players:-

The major players operating in the Gene Expression Analysis Industry include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Bio-Rad Laboratories, Inc. (US) are the key players in the gene expression analysis market.

Patient Registry Software Market: Trends and Developments

The growth of this market is mainly attributed to the shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software.

The report Patient Registry Software Market  is projected to reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4% from 2020 to 2025.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594

Market Segmentation:-

Based on the type of registry, the patient registry software market is segmented into product registries, health service registries, and disease registries. The disease registries segment accounted for the largest share of 67.2% of the patient registry software market in 2019.

Based on the deployment model, the Patient Registry Software Industry is segmented into on-premise model and cloud-based model. In 2019, on-premise models held 82.6% of the global patient registry software market. The large share of this segment can be attributed to the enhanced control and safety of patient data, and the large number of COVID-19 patients across the globe, which has driven the demand for registries.

Based on functionality, the population health management (PHM) segment accounted for the largest market share of 28.9% in 2019. The large share of this segment can be primarily attributed to the implementation of favorable regulations, such as the ACA in the US.

Based on the end user, the Patient Registry Software Industry is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & TPAs. In 2019, the government organizations & TPAs segment accounted for the largest share of 33.9% of the global patient registry software market.

Recent Developments

• In June 2020, ArborMetrix Inc. (US) entered into a partnership with The Society of Interventional Radiology (SIR) (US) . This partnership aims to provide the IR Quality Registry to improve patient care by integrating analytics.
• In April 2020, IQVIA Holdings Inc. (US), announced the launch COVID-19 registry platform and technology-powered trial matching solution
• In March 2020, OpenText Corporation (Canada) acquired XMedius (US) To strengthen OpenText’s leadership in the areas of secure information exchange, unified communications, and digital fax.
• In March 2020, ImageTrend Inc. (US) entered into a partnership with American Heart Association (US) , in this partnership ImageTrend’s Clinical and Research team will analyze pre-hospital data related to heart attacks and strokes in patients during the COVID-19 pandemic.
• InJanuary 2020, M2S . (US) announced the launch Vascular Medicine Consult Registry.

 

Regional Analysis:-

The patient registry software market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share of 48.9% of the global patient registry software market.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=144694594

Top key Players:-

Some of the prominent players in this market are Phytel, Inc. (US), IQVIA Holdings, Inc. (US), OpenText Corporation (Canada), ImageTrend, Inc. (US), FIGmd, Inc. (US), Syneos Health Inc. (US) and McKesson Corporation (US).

 

360quadrants Releases Quadrant on Best Human Resource Software Vendors

 Human Resource Software is a digital solution that helps handle and improve the routine human resource responsibilities and general human resource objectives of an enterprise. The software enables HR professionals to manage their time and resources efficiently in order to be more productive. The main objective of a Human Resource software is to help an organization’s HR team with automation, arranging employee data, and creating informative reports. It also helps manage activities such as time tracking, updating employee data, and managing and improving performance.

360Quadrants has analyzed the companies offering the best Human Resource Software. This analysis will help businesses select the software that best suits their requirements. The analysis has been based on critical parameters taken from the company’s product offerings and business strategies. 360Quadrants also helps businesses by providing critical insights derived from conducting a SWOT analysis. 

Human Resource Software 360quadrants Positioning 

360Quadrants studied over 175 companies that provide best Human Resource Software solutions. Amongst all, the top 10 Human Resource Software providers were shortlisted and positioned on a quadrant under the following categories: Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Leaders. 

Paylocity, ADP Vantage, Workday HCM, Kronos Workforce Ready, SAP Successfactors, and Zoho People were positioned as Visionary Leaders.

Oracle HCM Cloud was acknowledged as an Innovator.  
Cascade HR was recognized as an Emerging Company.  
Vibe HCM and iSolved were categorized as Dynamic Differentiators. 

360quadrants Scoring Approach:

Some of the finest software vendors offering the best Human Resource Software were rated by experts in the Human Resources space, with the help of a scoring methodology developed by 360Quadrants. All of these top Human Resource Software vendors were evaluated based on the 100+ parameters which were collected from their product offerings, business strategies, and responses from buyers and industry experts. All of the critical parameters and responses from buyers and industry experts were carefully assessed, after which a closing score was assigned to all the HR software vendors on the evaluation list. Finally, each software vendor was placed on a relative position on the 360Quadrant.

Suggested Read: 360quadrants Releases Best HR Software companies Of 2020

Needles Market to Witness Steady Growth in the Near Future

Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases are the major factors driving the growth of the needles market across the globe.

The Needles Market is expected to reach USD 8.47 Billion by 2022, at CAGR of 7.8% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930

Market Segmentation:-              

On the basis of type, the global needles market is segmented into two broad categories, namely, conventional needles and safety needles. The conventional needles market is estimated to command the larger share of the global needles market in 2017. The growing demand for biosimilar products, the increasing incidence of chronic disease, and the expanding injectables market are the key factors contributing to the growth of this market segment.

Based on product, the market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles.

The needles market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles on the basis of delivery mode. The hypodermic needles segment is expected to account for the largest share of the needles market in 2017.

Key Market Drivers: -
            1 High Prevalence of Chronic Diseases
            2 Growing Geriatric Population
            3 Increasing Number of Hospitals in Emerging Markets
            4 Increasing Demand for Vaccines

Regional Analysis:-

As of 2016, North America held the largest share of the global needles market, followed by Europe. Its dominant share is attributed to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood borne infections, and increasing prevalence of cardiovascular diseases.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223979930

Top Key Players:-

The key players in the global needles market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.).

 

Research Antibodies Market to witness major growth in coming years

Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and the growing collaboration between industries and academic institutes are the key drivers of the research antibodies market.

The Research Antibodies Market is expected to reach USD 12.60 Billion by 2022 from an estimated USD 9.33 Billion in 2017, at a CAGR of 6.2% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793

Market Segmentation:-

On the basis of product, the reagents segment accounted for the largest share of the global research antibodies market (including reagents), in 2016. This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques.

Based on technology, the western blotting segment accounted for the largest share of the Research Reagents Market. Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth.

Based on application, the proteomics segment accounted for the largest share of the Research Reagents Market. The large share of this segment is attributed to the deployment of proteomic-based approaches in biomarker detection and cancer profiling, increasing R&D expenditure, and availability of funds from various organizations.

Based on end user, the pharmaceutical & biotechnological companies segment accounted for the largest share of the Research Antibodies and Reagents Market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector.

Key Market Opportunities: -
            1 High Growth Opportunities in Emerging Markets
            2 Increasing Demand for Personalized Medicine and Protein Therapeutics
            3 Growths in Stem Cell and Neurobiology Research
            4 Increasing Focus on Biomarker Discovery

Regional Analysis:-

North America accounted for the largest share of the Research Antibodies and Reagents Market in 2016, followed by Europe. This regional segment shows significant market growth opportunities owing to the increasing research activities in the fields of proteomics and genomics, favorable government funding initiatives, and the growing focus of stakeholders on research projects.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94212793

Top Key Players:-

The major players in the research antibodies market (including reagents) are Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.).

 

360quadrants Releases Quadrant on Best Project Management Software Providers

Project management software is a computer program that enables project managers and other team members to commence, plan, implement, track, and deliver projects of all sizes and kinds. Project management software has been created to plan and store project responsibilities and events, arrange agendas and deadlines, address project problems, allocate and manage project-related expenses, set up association and support among project members, manage quality, bring together project teams, and manage human resources as well as project updates. The best project management software allows businesses to manage their projects through all the phases of the project lifecycle, right from project ideation and commencement to project implementation and conclusion. 

360Quadrants has released a quadrant on best project management software to help businesses make quicker and more informed decisions. Ranking quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the project management industry. 360Quadrants conducts an in-depth SWOT analysis that helps service providers learn about new opportunities and areas where they lag behind their peers. It also helps clients choose the most appropriate vendor for their requirements.  

Read More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-project-management-software-providers

 CATEGORIZATION OF PROJECT MANAGEMENT SOFTWARE PROVIDERS 

360Quadrants evaluated 45 companies in the best Project Management Software market, out of which 18 were categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies. 

Asana, Smartsheet, Wrike, Airtable, Zoho Projects, Trello, Basecamp, MeisterTask, ClickUp, Teamwork, WorkFront, Aha! and Monday.com have been identified as Visionary Leaders, as they have established product portfolios and a robust market presence & business strategy. 

Proofhub, and Teamleader have been identified as Innovators, as they have focused product portfolios and innovative business strategies. 

Redmine has been identified as Emerging Companies, as they have niche product offerings and decent business strategies. 

Flow, Freedcamp, EasyProjects and Thrive have been recognized as Dynamic Differentiators, as they are largely dependent on their competitive R&D activities. 

Ophthalmic Surgical Instruments Market to Expand at a Healthy Growth Rate in the Coming Years

The ophthalmic surgical instruments market is segmented into femtosecond lasers, excimer lasers, other lasers, and refractive surgery instruments & kits. The femtosecond lasers segment accounted for the major share of the refractive surgery devices market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment is attributed to its benefits such as lower incidence of dry eyes, less induced aberrations, greater safety, faster uncorrected visual acuity recovery, less intraocular pressure (IOP) variation in the femtosecond-created flap, and growing number of femtosecond laser-assisted surgeries being performed across the globe.

What the Market Looks Like?

The global Ophthalmic surgical instruments market is projected to reach USD 11.18 Billion by 2022 from USD 8.36 Billion in 2017, at a CAGR of 6.0%. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of ophthalmic surgeries owing to the rising prevalence of eye diseases, technological advancement in ophthalmic surgical instruments, and government initiatives to increase awareness about visual impairment across the globe.

Based on product, the ophthalmology surgical instruments market is segmented into cataract surgery devices, vitreoretinal surgery devices, refractive surgery devices, glaucoma surgery devices, ophthalmic microscopes, and accessories. The cataract surgery devices segment accounted for the major share of the global ophthalmic surgical instruments market. The large share of this segment can primarily be attributed to the growing number of cataract surgeries across the globe. Glaucoma surgery devices segment is expected to register the highest growth during the forecast period. The high growth of this segment is attributed to the rising prevalence of glaucoma and technological advancements in the glaucoma surgical devices throughout the world.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11819932

What Drives the Market?

The growth of the global market for Ophthalmic Surgical Instruments is primarily influenced by the following factors:

·         Rising Prevalence of Eye Diseases

·         Technological Advancements in Ophthalmic Surgical Instruments

·         Increasing Government Initiatives to Control Visual Impairment                           

North America accounted for the largest share of the ophthalmology surgical instruments market in 2016, followed by Europe. The large share of this region is attributed to rising prevalence of ocular disorders owing to growing geriatric population in North America, increase in healthcare expenditure, technological advancements in instruments & devices used for minimally invasive surgeries, and increasing regulatory approvals.

Speak to Analyst for more Details:  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=11819932

 

Blood Screening Market: Trends and Developments

The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the key factors driving the growth of this market.

The Blood Screening Market  is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042

Market Segmentations:-

Based on product & service, the blood screening market is segmented into reagents and kits, instruments, and software and services. The reagents and kits segment accounted for the largest share of the blood screening market in 2019. The large share of this segment can be attributed to the high consumption and repeated use of reagents & kits in blood screening procedures. Also, the accessibility of a wide range of reagents and the need for reliable, specific, and fast detection of TTIs are driving the growth of the blood screening reagents & kits market.

Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period.

Recent Developments:-

• In September 2019, The US FDA approved cobas Babesia, Roche’s first whole-blood test for donor screening, in accordance with May 2019 FDA-updated industry guidance recommending screening and testing for Babesia.
• In February 2019, Grifols received FDA approval for the Procleix Babesia Assay for donor screening on its Procleix Panther System.
• In October 2016, Merck opened a new Life Science Center in Burlington, Massachusetts, to serve as a regional hub for scientific advancement and customer collaboration.

Regional Analysis:

Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=267747042

Key Players:-

The prominent players operating in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMérieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

HR Software | Types of Human Resource Software and Market Growth Drivers

 Different Types of HR Software:

Human Resource software is distributed into various groups that cover solutions right from benefits administration to workforce management software. The following are the types of HR software:

1. Talent management software:

HR software offers organization-wide employee oversight solutions. The features comprise career management, reimbursement management, employee engagement, and employee appreciation, etc.

2. HR analytics software:

HR professionals leverage Human Resource software solutions to gather and assess business data to help in enhancing productivity. These solutions track employee performance to support businesses in foreseeing productivity and enhancing workforce management.

3. Core HR software:

Core HR software helps in developing a central database through which employee information, such as payroll and benefits data, can be retrieved and preserved.

4. Benefits management software:

This software generally controls the benefits packages. It can be accessed by employees through a dedicated employee portal in which they can pick from the benefit plans provided by their employers.

5. Staffing software:

Staffing software helps in sourcing active and passive applicants on behalf of companies that employ them to manage their recruiting tasks.

6. Career management software:

Businesses use this software to allow their employees to handle their career development. Career management software can be integrated with other HR tools to deliver HR professionals and employee self-service solutions.

7. Payment management software:

Companies make use of the payment management software to handle employee compensation packages that include developing internal compensation plans and bonus structures.

8. Employee engagement software:

Employee engagement software helps businesses in leveraging pulse surveys to gather responses about employees and company satisfaction. Besides, employee engagement software enables organizations to use these responses to execute corporate wellness initiatives and recognize employees.

9. Employee recognition software:

HR personnel uses this software to set benchmarks for employee rewards, as well as track employee growth toward achieving the set goals and HR software help to achieve that. These tools also offer solutions that complement and sometimes integrate with, employee engagement tools.

10. Performance management software:

Businesses make use of this software to recognize and develop employee performance benchmarks that the management can leverage to assess employee job performance. These HR software often include 360-degree response tools that managers and employees can use to rate each other.

What are the major market drivers for HR Software?

The Human Resource market is driven by the progressions in IT, the inclusion of predictive analytics in the HR process, growth in the acceptance of cloud among SMEs to efficiently manage field and office personnel, among others.

Suggested Read: 360Quadrants Releases Best HR Software Companies of 2020